Risk of multiple primary malignancies following treatment of Hodgkin lymphoma.

MLA

van Eggermond, Anna M., et al. “Risk of Multiple Primary Malignancies Following Treatment of Hodgkin Lymphoma.” Blood, vol. 124, no. 3, July 2014, pp. 319–27. EBSCOhost, https://doi.org/10.1182/blood-2013-10-532184.

APA

van Eggermond, A. M., Schaapveld, M., Lugtenburg, P. J., Krol, A. D. G., de Boer, J. P., Zijlstra, J. M., Raemaekers, J. M. M., Kremer, L. C. M., Roesink, J. M., Louwman, M. W. J., Aleman, B. M. P., & van Leeuwen, F. E. (2014). Risk of multiple primary malignancies following treatment of Hodgkin lymphoma. Blood, 124(3), 319–327. https://doi.org/10.1182/blood-2013-10-532184

Chicago

van Eggermond, Anna M., Michael Schaapveld, Pieternella J. Lugtenburg, Augustinus D. G. Krol, Jan Paul de Boer, Josée M. Zijlstra, John M. M. Raemaekers, et al. 2014. “Risk of Multiple Primary Malignancies Following Treatment of Hodgkin Lymphoma.” Blood 124 (3): 319–27. doi:10.1182/blood-2013-10-532184.